Barthélémy, P., Loriot, Y., Thibault, C., Fléchon, A., Voog, E., Eymard, J. C., Simon, C., Pouessel, D., Chasseray, M., Lorgis, V., Josse, C., Lambert, P., Paret, L., Gross-Goupil, M. (2025). AVENANCE real-world study of avelumab first-line (1L) maintenance treatment for advanced urothelial carcinoma (UC): Analyses in low tumor burden subgroups.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.718